BioSpace News Archive

FDA

FDA Works to Get New Drugs to Patients Faster with Multiple Approvals This Week

The FDA uses special designations to get new, breakthrough treatments to patients in the greatest need.

December 1, 2020
·
3 min read
·
Kate Goodwin
3 Ways to Thank Your Network This Year

Without the ability to see as many people in person, how can you thank someone for their ongoing help and perpetual cheerleading? Here are a few ways to virtually thank your broader network.

December 1, 2020
·
2 min read
·
Laura Brothers
Business

Biopharma Money on the Move: November 25 – December 1

A roundup of which pharma and biotech companies are grabbing cash before the 2020 calendar closes.

December 1, 2020
·
4 min read
·
Kate Goodwin
Business

Swiss Startup Hits the Ground Running for Rare Neurological Diseases

Noema Pharma raised $59 million in a Series A financing round that will support the development of four clinical-stage assets the company licensed from Roche for the treatment of orphan neurological diseases with severe unmet needs.

December 1, 2020
·
2 min read
·
Alex Keown
Drug Development

Biopharma Update on the Novel Coronavirus: December 1

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 1, 2020.

December 1, 2020
·
3 min read
·
BioSpace Editorial Staff
Policy

Defying Skeptics, Pfizer and Moderna Gun for Global COVID-19 Vaccine Approval

As the year winds down, the top companies in the COVID-19 vaccine race are nearing the finish line in the United States and other countries around the world.

December 1, 2020
·
6 min read
·
Mark Terry
Business

End of Year, Change of Careers - Arena and Genentech Switch Up Execs

Although biopharma executives leave for many reasons and at any time, there is a tendency to make shifts toward the end of the year. Today there were two high-profile announcements to start off the month of December.

December 1, 2020
·
3 min read
·
Mark Terry
Drug Development

Hope Shines Through as Axsome Seeks Approval for MDD Drug

Shares of Axsome were up more than 7% in premarket trading after the company announced positive, long-term results from its Phase III Major Depressive Disorder study that sets the company up for potential regulatory approval.

December 1, 2020
·
3 min read
·
Alex Keown
Job Trends

Growing Opportunities – The Latest Job Expansions in the Life Sciences Industry

Amidst a global pandemic, the life sciences industry is booming! BioSpace rounds up facility expansions and employment opportunities across the states and beyond.

December 1, 2020
·
5 min read
·
Kate Goodwin
Drug Development

Trial Drug Shows Promise in Treating Cognitive Impairment Associated with Schizophrenia

Despite a number of anti-psychotic medications available, there are no approved drugs to address underlying cognitive development issues. Cerevance aims to change that.

December 1, 2020
·
3 min read
·
Alex Keown